- $619.42m
- $655.86m
- $749.60m
- 92
- 73
- 57
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 820 | 493 | 615 | 816 | 750 |
Cost of Revenue | |||||
Gross Profit | 135 | 19.4 | 85.2 | 122 | 139 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 810 | 571 | 625 | 825 | 716 |
Operating Profit | 10.4 | -78.2 | -9.82 | -9.03 | 33.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.16 | -92.6 | -18.2 | -16.5 | 25.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.9 | -80.7 | -25.5 | -20.8 | 14.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.9 | -80.7 | -25.5 | -20.8 | 14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.9 | -80.7 | -25.5 | -20.8 | 14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.061 | -0.892 | -0.245 | 0.04 | 0.243 |